Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

<p>Supplementary Figure 5: Copy number variants in the three main glioblastoma groups according to classifier v12.5. A Copy number variants in all patients combined (n = 295), B in RTK1 tumors (n = 89), C in RTK2 tumors (n = 140) and D in MES tumors (n = 66). PDGFRA amplifications are enriched...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Tobias Kessler (17079209) (author)
مؤلفون آخرون:	Daniel Schrimpf (17079212) (author), Laura Doerner (17079215) (author), Ling Hai (17079218) (author), Leon D. Kaulen (17079221) (author), Jakob Ito (17079224) (author), Martin van den Bent (17079227) (author), Martin Taphoorn (17079230) (author), Alba A. Brandes (17079233) (author), Ahmed Idbaih (17079236) (author), Julien Dômont (17079239) (author), Paul M. Clement (15044256) (author), Mario Campone (15027156) (author), Martin Bendszus (17079242) (author), Andreas von Deimling (15037904) (author), Felix Sahm (15097382) (author), Michael Platten (15018165) (author), Wolfgang Wick (15018168) (author), Antje Wick (17079245) (author)
منشور في:	2025
الموضوعات:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

مواد مشابهة